New proteins inhibit HIV infection in cell cultures

July 24, 2012 By Helen Dodson
Credit: Peter Baker

(Medical Xpress) -- Yale Cancer Center scientists have developed a new class of proteins that inhibit HIV infection in cell cultures and may open the way to new strategies for treating and preventing infection by the virus that causes AIDS. The findings appear in the online edition of the Journal of Virology.

AIDS slowly weakens the immune system and allows life-threatening infections and cancers to thrive. The Yale team isolated six 43- and 44-amino acid proteins that inhibited cell-surface and total expression of an essential HIV receptor and blocked in laboratory .

The proteins were modeled after a protein from a papillomavirus that causes warts in cows. This bovine is related to the human papillomaviruses that cause and some head and neck cancers.

“We have constructed an entirely new class of proteins that inhibit HIV infection. These proteins do not occur in nature, so our findings suggest a radical new strategy to prevent AIDS,” said senior author Dr. Daniel DiMaio, deputy director of the Yale Cancer Center, and Waldemar Von Zedtwitz, professor of genetics at Yale School of Medicine. “If these proteins are found to be active in people, they may provide a way to prevent AIDS and its consequences, including cancer.”

Research on papillomaviruses began in the DiMaio laboratory almost 30 years ago, before the AIDS epidemic had emerged and the role of papillomaviruses in cancer was known.

“Of course, there are many hurdles to taking a laboratory finding like this into the clinic, but because these proteins dramatically inhibit HIV in cell culture, they should be evaluated further,” DiMaio explained.

Other authors are Richard A. Sutton, Elizabeth H. Scheideman, Sara A. Mariatt, Yanhua Xie, and Yani Hu, all of Yale.

Explore further: Sugar-binding protein may play a role in HIV infection

More information: Support for the project was provided by the National Cancer Institute (CA37157); the National Institute of Allergy and Infectious Diseases (AI067034); the American Cancer Society (PF-11-273-01-TBE); the James Hudson Brown-Alexandrer Brown Coxe Foundation; and the National Institutes of Health (T32 GM007499). This work was also supported by a donation to Yale Cancer Center by Laurel Schwartz.

Related Stories

Sugar-binding protein may play a role in HIV infection

June 14, 2011
Specific types of "helper" T cells that are crucial to maintaining functioning immune systems contain an enzyme called PDI (protein disulfide isomerase).

Recommended for you

New approach helps rodents with spinal cord injury breathe on their own

October 17, 2017
One of the most severe consequences of spinal cord injury in the neck is losing the ability to control the diaphragm and breathe on one's own. Now, investigators show for the first time in laboratory models that two different ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

New method to measure how drugs interact

October 17, 2017
Cancer, HIV and tuberculosis are among the many serious diseases that are frequently treated with combinations of three or more drugs, over months or even years. Developing the most effective therapies for such diseases requires ...

A new compound targets energy generation, thereby killing metastatic cells

October 17, 2017
Cancer can most often be successfully treated when confined to one organ. But a greater challenge lies in treating cancer that has metastasized, or spread, from the primary tumor throughout the patient's body. Although immunotherapy ...

Research finds that zinc binding is vital for regulating pH levels in the brain

October 17, 2017
Researchers in Oslo, Norway, have discovered that zinc binding plays an important role in the sensing and regulation of pH in the human brain. The findings come as one of the first studies that directly link zinc binding ...

Researchers find factor that delays wound healing

October 17, 2017
New research carried out at The University of Manchester has identified a bacterium—normally present on the skin that causes poor wound healing in certain conditions.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.